PL3124026T3 - Preparat iniekcyjny i sposób jego wytwarzania - Google Patents

Preparat iniekcyjny i sposób jego wytwarzania

Info

Publication number
PL3124026T3
PL3124026T3 PL14886906T PL14886906T PL3124026T3 PL 3124026 T3 PL3124026 T3 PL 3124026T3 PL 14886906 T PL14886906 T PL 14886906T PL 14886906 T PL14886906 T PL 14886906T PL 3124026 T3 PL3124026 T3 PL 3124026T3
Authority
PL
Poland
Prior art keywords
producing same
injection preparation
injection
preparation
producing
Prior art date
Application number
PL14886906T
Other languages
English (en)
Inventor
Shinichi Hashimoto
Shigetomo Tsujihata
Yasuyuki Izumi
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of PL3124026T3 publication Critical patent/PL3124026T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PL14886906T 2014-03-28 2014-12-26 Preparat iniekcyjny i sposób jego wytwarzania PL3124026T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014069613 2014-03-28
EP14886906.8A EP3124026B1 (en) 2014-03-28 2014-12-26 Injection preparation and method for producing same
PCT/JP2014/084543 WO2015145911A1 (ja) 2014-03-28 2014-12-26 注射液製剤及びその製造方法

Publications (1)

Publication Number Publication Date
PL3124026T3 true PL3124026T3 (pl) 2019-03-29

Family

ID=54194477

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14886906T PL3124026T3 (pl) 2014-03-28 2014-12-26 Preparat iniekcyjny i sposób jego wytwarzania

Country Status (8)

Country Link
US (1) US10391052B2 (pl)
EP (1) EP3124026B1 (pl)
JP (1) JP6099810B2 (pl)
CN (1) CN106132416B (pl)
DK (1) DK3124026T3 (pl)
ES (1) ES2686870T3 (pl)
PL (1) PL3124026T3 (pl)
WO (1) WO2015145911A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI4011377T3 (fi) 2015-02-13 2025-01-07 Sun Pharmaceutical Ind Ltd Suonensisäinen infuusioannosmuoto sisältäen pemetreksediä
KR101693675B1 (ko) * 2015-12-14 2017-01-06 주식회사 종근당 페메트렉시드 또는 그의 약제학적으로 허용가능한 염을 함유하는 안정화된 약학조성물
JP6854710B2 (ja) * 2017-06-14 2021-04-07 日本化薬株式会社 ペメトレキセドを含有する注射用溶液製剤
JP2019094284A (ja) * 2017-11-21 2019-06-20 日本化薬株式会社 ペメトレキセドを含有する注射用溶液製剤
US12280053B2 (en) * 2019-05-01 2025-04-22 Intas Pharmaceuticals Ltd. Stable, ready to use aqueous pharmaceutical composition of pemetrexed

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521518A (ja) * 2000-02-04 2003-07-15 イーライ・リリー・アンド・カンパニー モノチオグリセロール、l−システインまたはチオグリコール酸とともにペメトレクストを含む医薬組成物
US6686365B2 (en) 2000-02-04 2004-02-03 Eli Lilly And Company Pharmaceutical composition
US9655898B2 (en) 2010-07-28 2017-05-23 Eagle Pharmaceuticals, Inc. Pharmaceutical compositions containing pemetrexed having extended storage stability
KR101069128B1 (ko) 2011-03-10 2011-09-30 건일제약 주식회사 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법
SI2854768T1 (sl) * 2012-05-30 2017-08-31 Fresenius Kabi Oncology Limited Farmacevtski sestavki pemetrekseda
KR101260636B1 (ko) * 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
CN105611932B (zh) * 2013-10-03 2019-02-12 富士胶片株式会社 注射液制剂及其制造方法

Also Published As

Publication number Publication date
CN106132416B (zh) 2019-03-26
DK3124026T3 (en) 2018-10-01
CN106132416A (zh) 2016-11-16
US20170007538A1 (en) 2017-01-12
JPWO2015145911A1 (ja) 2017-04-13
EP3124026A4 (en) 2017-03-22
EP3124026A1 (en) 2017-02-01
JP6099810B2 (ja) 2017-03-22
EP3124026B1 (en) 2018-07-25
ES2686870T3 (es) 2018-10-22
US10391052B2 (en) 2019-08-27
WO2015145911A1 (ja) 2015-10-01

Similar Documents

Publication Publication Date Title
SG11201700035RA (en) Method and device for producing coffee
PL3023308T3 (pl) Element okładziny wewnętrznej oraz sposób jego wytwarzania
HUE053278T2 (hu) Eljárás sajtolt idomok és termékek elõállítására
ZA201505683B (en) Additive manufacturing system and method
PL3196196T3 (pl) Sposób wytwarzania kalcobutrolu
PL3040074T3 (pl) Preparat iniekcyjny i sposób jego wytwarzania
SG11201604865SA (en) Improved method for producing ginkgo extracts
SG11201701326YA (en) Method for producing oligosilane
SG11201702341VA (en) Doughnuts and method for producing same
PL3157889T3 (pl) Kompozycja mocznikowa i sposób jej wytwarzania
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
PL3110349T3 (pl) Igła implantacyjna i sposób wytwarzania
IL246831B (en) A method for the production of 1-indanols and 1-indanamines
PL3124026T3 (pl) Preparat iniekcyjny i sposób jego wytwarzania
PL3328757T3 (pl) Torebka filtrująca do produktów infuzyjnych i sposób wytwarzania torebki filtrującej
SG11201701354VA (en) Oligosaccharide preparation and method for producing the same
IL246870B (en) Method for preparing 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carboxylates
PL3126144T3 (pl) Tworzywo warstwowe i sposób jego wytwarzania
ZA201704640B (en) Silybin injection and preparation method therefor
IL250223B (en) A method for the preparation of the pyrimidine-1-ol compound, and its intermediates
SG11201701075UA (en) Method for producing dip-formed article, and dip-formed article
HUE051762T2 (hu) L-glutamin elõállítására szolgáló mikroorganizmus és eljárás L-glutamin elõállítására annak alkalmazásával
EP3144329A4 (en) Cross-copolymer and method for producing same
GB201415250D0 (en) Compound and method
SG11201702531TA (en) Collagen construct and method for producing the collagen construct